S. Chace Lottich

The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3)

Cheryl A. Szpak, W W Johnston, Victor L. Roggli et al. · Lung Cancer · 1987 · 121 citations

Malignant Mesothelioma, Histopathology, Pathology +9

Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.

W W Johnston, Cheryl A. Szpak, S. Chace Lottich et al. · PubMed · 1985 · 105 citations

Breast Oncology, Immunocytochemical Technique, Immunology +17

Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens

William W. Johnston, Cheryl A. Szpak, S. Chace Lottich et al. · Human Pathology · 1986 · 73 citations

Tumor Biology, Immunocytochemical Technique, Medicine +10

Detection and characterization using circular dichroism and fluorescence spectroscopy of a stable intermediate conformation formed in the denaturation of bovine carbonic anhydrase with guanidinium chloride

Robert W. Henkens, Barbara B. Kitchell, S. Chace Lottich et al. · Biochemistry · 1982 · 65 citations

Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.

Cheryl A. Szpak, W W Johnston, S. Chace Lottich et al. · PubMed · 1984 · 64 citations

Breast Oncology, Immunology, Human Malignant +18